Nitric Oxide Synthase 1 Adaptor Protein, an Emerging New Genetic Marker for QT Prolongation and Sudden Cardiac Death.
Sudden cardiac death (SCD) is defined as sudden unexplained death due to cardiac causes with an acute change in cardiovascular status within 1 hour of onset of symptoms. Alternatively, in unwitnessed cases, SCD can also be defined as a person last seen functionally normal 24 hours before being found dead. Despite significant advances in understanding the pathophysiology of cardiovascular diseases and the resultant improvement in resuscitation science, SCD remains a major healthcare challenge worldwide. Although the most pronounced risk factor for SCD is the presence of coronary artery disease in the setting of a depressed left ventricular function, most deaths occur in the larger, lower-risk subgroups where genetic variations and other conditions may be the precipitating factors in triggering SCD. Recently, a common genetic variation in a neuronal nitric oxide synthase regulator, nitric oxide synthase 1 adaptor protein (NOS1AP) also known as carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase protein (CAPON) gene, has been identified as a new genetic marker in modulating QT interval prolongation and SCD in general populations. Animal study revealed that NOS1AP is expressed in the heart and interacts with NOS1-NO pathways to modulate cardiac repolarization via suppressing the sarcolemmal L-type calcium current and enhancing the IKr current. This important genetic implication was soon replicated in other racial/ethnic populations and extended to a variety of clinical settings including diabetes mellitus, coronary artery disease, myocardial infarction, and congenital or drug-induced long QT syndrome. The purpose of this review aims to provide up-to-date information about the emerging new genetic marker, NOS1AP, in relation to QT prolongation and SCD.


BACKGROUND
NOS1AP; QT interval; Sudden cardiac death.
Division of Cardiology, Department of Medicine, China Medical University Hospital; ; Graduate Institute of Clinical Medical Science, China Medical University, Taichung, Taiwan;
Kuan-Cheng
KC
Chang
Department of Biofunctional Informatics, Tokyo Medical and Dental University, Tokyo, Japan;
Tetsuo
T
Sasano
Division of Cardiology, Department of Medicine, China Medical University Hospital; ; Graduate Institute of Clinical Medical Science, China Medical University, Taichung, Taiwan;
Yu-Chen
YC
Wang
Section of Cardiac Electrophysiology and Pacing, Scott & White Healthcare, Texas A & M University College of Medicine, Temple, TX, USA.
Shoei K Stephen
SK
Huang